Acquisition Update & Issue of Equity

UDG Healthcare plc

Acquisition Update: Issue of Equity

23 November 2016: Further to the previous announcement by UDG Healthcare plc ("the Company") on 21 October 2016, the Company confirms the issue of 724,997 ordinary shares of €0.05 each in the Company as part of the initial consideration for the completion of the acquisition of STEM Marketing Limited, the leading global provider of commercial, marketing and medical audits to pharmaceutical companies. The shares were issued at £6.604, the average daily mid-market share price of the Company over the 15 business days post the original announcement date of 21 October 2016.

The new ordinary shares rank pari passu with the existing ordinary shares in the Company. Applications have been made for the new ordinary shares to be admitted to the Official List of the FCA and to trading on the London Stock Exchange's main market for listed securities. Admission is expected to take place on 24 November 2016.

Following issuance of the new ordinary shares, the Company's issued share capital will consist of 247,489,466 ordinary shares of €0.05 each. Each ordinary share carries one vote. The Company also holds 7,528,066 ordinary shares in treasury, which do not carry voting rights. Therefore, the total number of voting rights in the Company is 247,489,466. The above figure may be used by shareholders as a denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, UDG Healthcare plc under the Transparency (Directive 2004/109/EC) Regulations 2007.

Contact:

Keith Byrne

Head of Investor Relations & Strategy

Tel: +353-1-468 9000